The unlikely, but possible, 25% tariffs on Prescription Medications and Medical Equipment and the potential impacts on Canadian Insurance Premiums.
The imposition of a 25% tariff on Canadian goods by the U.S. could indirectly affect the pharmaceutical sector and have broader economic consequences, including potential impacts on employee group insurance plan premiums. Here’s how: 1. Increased Costs for Pharmaceutical Ingredients Many active pharmaceutical ingredients (APIs) used in Canadian medications are sourced internationally, including from the U.S. Tariffs […]